Stay Up to Date
Featured News
FDA APPROVES OGSIVEO™ (NIROGACESTAT), AS THE FIRST MEDICAL THERAPY FOR THE TREATMENT OF ADULTS WITH PROGRESSING DESMOID TUMORS.
Filter by:
October 4, 2021
Update: DTRF Submits Proposal To CDC For Specific ICD-10 Code For Desmoid Tumors
Read More about Update: DTRF Submits Proposal To CDC For Specific ICD-10 Code For Desmoid Tumors
September 30, 2021
Desmoid Tumor Awareness Month 2021 Comes To A Close
Read More about Desmoid Tumor Awareness Month 2021 Comes To A Close
September 27, 2021
DTRF Hosts Successful 2021 Virtual DTRF “Together We Will” Weekend
Read More about DTRF Hosts Successful 2021 Virtual DTRF “Together We Will” Weekend
March 3, 2021
DTRF Awarded The 2021 “Abbey S. Meyers Leadership Award”, A Nord “Rare Impact Award”
Read More about DTRF Awarded The 2021 “Abbey S. Meyers Leadership Award”, A Nord “Rare Impact Award”
March 7, 2019
Big News! DTRF’s First Grant Of 2019 Awarded To The Broad Institute Of MIT And Harvard
Clinical Trials December 20, 2018
